MIRM NASDAQ
Mirum Pharmaceuticals, Inc.
1W: -9.6%
1M: +6.7%
3M: -4.3%
YTD: +28.9%
1Y: +122.0%
3Y: +282.9%
5Y: +485.3%
$98.62
-2.05 (-2.04%)
Weekly Expected Move ±8.6%
$85
$93
$102
$111
$120
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026345
Institutions Holding
+13 vs prior
107.0%
Ownership
+12.39%
62
New
97
Increased
149
Reduced
71
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Ramasastry Saira | director | S-Sale | 2,000 | $109.47 | $219K | Filing |
| 2026-04-15 | Ramasastry Saira | director | S-Sale | 2,000 | $96.90 | $194K | Filing |
| 2026-03-16 | Peetz Christopher | officer: chief executive officer | S-Sale | 40,985 | $91.98 | $3.8M | Filing |
| 2026-03-16 | Howe Jolanda | officer: svp, global controller | S-Sale | 4,732 | $91.98 | $435K | Filing |
| 2026-03-16 | Radovich Peter | officer: president and coo | S-Sale | 16,515 | $91.98 | $1.5M | Filing |
| 2026-03-16 | Ramasastry Saira | director | S-Sale | 2,000 | $90.76 | $182K | Filing |
| 2026-03-16 | Quan Joanne | officer: chief medical officer | S-Sale | 7,287 | $91.98 | $670K | Filing |
| 2026-03-16 | BJERKHOLT ERIC | officer: chief financial officer | S-Sale | 7,287 | $91.98 | $670K | Filing |
| 2026-02-13 | Ramasastry Saira | director | S-Sale | 2,000 | $102.09 | $204K | Filing |
| 2026-02-02 | Howe Jolanda | officer: svp, global controller | S-Sale | 968 | $103.30 | $100K | Filing |
| 2026-02-02 | Radovich Peter | officer: president and coo | S-Sale | 2,631 | $103.30 | $272K | Filing |
| 2026-02-02 | Peetz Christopher | officer: chief executive officer | S-Sale | 9,108 | $103.30 | $941K | Filing |
| 2026-01-26 | Peetz Christopher | officer: chief executive officer | S-Sale | 6,831 | $96.19 | $657K | Filing |
| 2026-01-26 | Radovich Peter | officer: president and coo | S-Sale | 3,143 | $96.19 | $302K | Filing |
| 2026-01-26 | Howe Jolanda | officer: svp, global controller | S-Sale | 842 | $96.19 | $81K | Filing |
| 2026-01-26 | BJERKHOLT ERIC | officer: chief financial officer | S-Sale | 1,053 | $96.19 | $101K | Filing |
| 2026-01-23 | Heron Patrick J | director | J-Other | 159,277 | $— | $0 | Filing |
| 2026-01-23 | Heron Patrick J | director | P-Purchase | 131,425 | $68.48 | $9.0M | Filing |
| 2026-01-22 | Quan Joanne | officer: chief medical officer | S-Sale | 1,822 | $93.33 | $170K | Filing |
| 2026-01-22 | Radovich Peter | officer: president and coo | S-Sale | 2,382 | $93.33 | $222K | Filing |
| 2026-01-22 | Peetz Christopher | officer: chief executive officer | S-Sale | 7,098 | $93.33 | $662K | Filing |
| 2026-01-22 | Howe Jolanda | officer: svp, global controller | S-Sale | 926 | $93.33 | $86K | Filing |
| 2026-01-22 | BJERKHOLT ERIC | officer: chief financial officer | S-Sale | 1,421 | $93.33 | $133K | Filing |
| 2026-01-20 | Quan Joanne | officer: chief medical officer | S-Sale | 6,911 | $90.27 | $624K | Filing |
| 2026-01-15 | Ramasastry Saira | director | S-Sale | 2,000 | $90.99 | $182K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 7,679,684 | $709M | +884,563 | 2026-03-31 | Filing |
| JANUS HENDERSON GROUP PLC | 6,945,813 | $642M | +880,505 | 2026-03-31 | Filing |
| BlackRock, Inc. | 3,846,530 | $355M | +201,244 | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,414,776 | $223M | +2,414,776 | 2026-03-31 | Filing |
| FMR LLC | 1,965,375 | $182M | +1,318,909 | 2026-03-31 | Filing |
| STATE STREET CORP | 1,944,281 | $180M | -199,711 | 2026-03-31 | Filing |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1,432,083 | $132M | +1,432,083 | 2026-03-31 | Filing |
| EVENTIDE ASSET MANAGEMENT, LLC | 1,408,871 | $130M | -684,711 | 2026-03-31 | Filing |
| WELLINGTON MANAGEMENT GROUP LLP | 1,334,809 | $123M | +96,979 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,260,003 | $116M | +197,077 | 2026-03-31 | Filing |
| TANG CAPITAL MANAGEMENT LLC | 1,236,027 | $114M | — | 2026-03-31 | Filing |
| TCG Crossover Management, LLC | 1,062,049 | $98M | +1,000,000 | 2026-03-31 | Filing |
| BNP PARIBAS FINANCIAL MARKETS | 911,419 | $84M | +255,641 | 2026-03-31 | Filing |
| Rock Springs Capital Management LP | 811,294 | $75M | +49,000 | 2026-03-31 | Filing |
| Capital World Investors | 724,415 | $67M | +724,415 | 2026-03-31 | Filing |
| BANK OF AMERICA CORP /DE | 722,177 | $67M | +8,725 | 2026-03-31 | Filing |
| FRANKLIN RESOURCES INC | 714,804 | $66M | +64,089 | 2026-03-31 | Filing |
| Clearbridge Investments, LLC | 671,870 | $62M | -194,097 | 2026-03-31 | Filing |
| GOLDMAN SACHS GROUP INC | 662,306 | $61M | -62,011 | 2026-03-31 | Filing |
| Paradigm Biocapital Advisors LP | 625,000 | $58M | +625,000 | 2026-03-31 | Filing |